ClinicalTrials.Veeva

Menu
C

Calvary North Adelaide Hospital | Oncology Clinical Trials

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Docetaxel
Radium-223 Dichloride
AGEN2034
Rindopepimut
INCB050465
Xofigo
GM-CSF
CPI-0610
Paclitaxel
Pelabresib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 8 total trials

Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH

Researchers in this study want to compare how well drug radium-223 dichloride (Xofigo) and new (novel) anti-hormonal (NAH) therapy work in participan...

Active, not recruiting
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Drug: NAH therapy
Drug: Radium-223 dichloride (Xofigo, BAY88-8223)

A Phase 3, randomized, blinded study comparing pelabresib (CPI-0610) and ruxolitinib with placebo and ruxolitinib in myelofibrosis (MF) patients that...

Active, not recruiting
Myelofibrosis
Post-essential Thrombocythemia Myelofibrosis
Drug: Placebo
Drug: Pelabresib

This is a randomized, positive-controlled, open-label, international multicenter, Phase 3 clinical study to compare the efficacy and safety of pyroti...

Active, not recruiting
HER2 Exon 20 Mutation
Non-squamous NSCLC
Drug: Pyrotinib
Drug: Docetaxel

This is an open-label, multicenter, nonrandomized Phase 1 and 2 clinical trial evaluating various combinations of BGB-A425 and/or LBL-007 with tislel...

Enrolling
Locally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2
Drug: Tislelizumab
Drug: LBL-007

Trial sponsors

Agenus logo
Bayer logo
BeiGene logo
Celgene logo
Celldex Therapeutics logo
C
Hengrui Medicine logo
Incyte logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems